Revenue
2022
2023
2024
2025
Liminatus Pharma, Inc. (LIMN)
Price$3.66Cached quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & development | $0 | $2.7M | $3.8M | $1.9M |
| Operating expenses | $3.0M | $3.3M | $4.8M | $2.7M |
| Operating income | −$3.0M | −$3.3M | −$4.8M | −$2.7M |
| EBITDA | −$3.0M | −$3.2M | −$4.8M | −$2.7M |
| Net income | −$10.2M | −$3.5M | −$5.0M | −$2.9M |
| Basic EPSper basic share | -$0.43 | -$0.20 | -$0.19 | -$0.11 |
| Diluted EPSper diluted share | -$0.43 | -$0.20 | -$0.19 | -$0.11 |
Owners
Reported shareholders
≈12.33%of listed shares
Iris Acquisition Holdings LLC6.9M shares · Apr 30, 2025
View holders
| Holder | % owned |
|---|---|
Iris Acquisition Holdings LLC | ≈12.33%6.9M shares |
Valetudo Therapeutics LLC / Kim Chris | ≈11.02%6.17M shares |
KH Feelux Co., Ltd | ≈7.15%4M shares |
XTX Topco Ltd | 0.40%221.84K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.25%138.42K shares |
CITADEL ADVISORS LLC | 0.10%56.09K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.09%50.44K shares |
GOLDMAN SACHS GROUP INC | 0.07%40.22K shares |
StoneX Group Inc. | 0.05%26.06K shares |
VANGUARD FIDUCIARY TRUST CO | 0.04%22.98K shares |
STATE STREET CORP | 0.03%19K shares |
UBS Group AG | 0.03%16.73K shares |
Vanguard Personalized Indexing Management, LLC | 0.02%13.15K shares |
Tower Research Capital LLC (TRC) | 0.01%7.09K shares |
BARCLAYS PLC | <0.01%4.29K shares |
BlackRock, Inc. | <0.01%313 shares |
Percentages use 55.97M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data